etoposide has been researched along with Myeloproliferative Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Lei, P; Li, Y; Liu, L; Zhai, Y; Zhang, Y | 1 |
| Abe, M; Arai, J; Katayama, N; Kato, K; Kobayashi, C; Koike, K; Mouri, Y; Shiono, J; Tsuchida, M; Yanase, K; Yoshimi, A | 1 |
| Adachi, Y; Arimura, Y; Endo, T; Ishii, Y; Sawada, T; Yasui, H | 1 |
| Dirnhofer, S; Girsberger, S; Karow, A; Lehmann, T; Lundberg, P; Passweg, JR; Rovó, A; Skoda, R; Tichelli, A | 1 |
| Kaya, H; Kobayashi, K; Matano, S; Nakamura, S; Sugimoto, T; Yoshida, T | 1 |
| Amigo, ML; Caballero, MD; del Cañizo, C; García, R; Gonzalez, M; Hernández, JM; San Miguel, JF; Vazquez, L | 1 |
| Readett, D; Richards, M; Vora, AJ; Watmore, A; Welch, J | 1 |
| Arakawa, S; Esumi, N; Imashuku, S; Todo, S | 1 |
8 other study(ies) available for etoposide and Myeloproliferative Disorders
| Article | Year |
|---|---|
Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Humans; Male; Myeloproliferative Disorders; Phenotype; Precancerous Conditions; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Syndrome; Translocation, Genetic; Vincristine | 2010 |
Transient abnormal myelopoiesis in a cytogenetically normal neonate.
Topics: Antineoplastic Agents; Cytarabine; Cytogenetic Analysis; Down Syndrome; Etoposide; Exons; GATA1 Transcription Factor; Humans; Infant, Newborn; Karyotyping; Mutation; Myelopoiesis; Myeloproliferative Disorders | 2010 |
Esophageal lesions in myeloproliferative neoplasms.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Esophageal Neoplasms; Etoposide; Humans; Male; Myeloproliferative Disorders; Prednisolone; Ulcer | 2012 |
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
Topics: Alleles; Antineoplastic Agents; Bone Marrow Neoplasms; Drug Therapy, Combination; Etoposide; Humans; Janus Kinase 2; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Mutation; Myeloproliferative Disorders; Pancreatic Neoplasms | 2013 |
[Low-dose combination cytarabine and etoposide for myeloid crisis transformed from unclassified chronic myeloproliferative disorder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Chronic Disease; Cytarabine; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Myeloproliferative Disorders | 1996 |
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methylprednisolone; Middle Aged; Myeloproliferative Disorders; Neutropenia; Salvage Therapy; Survival Rate; Time Factors | 1997 |
Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 6; Cytarabine; Down Syndrome; Etoposide; Female; Hematopoietic Stem Cells; Humans; In Situ Hybridization, Fluorescence; Infant, Newborn; Karyotyping; Male; Mitoxantrone; Myeloproliferative Disorders; Time Factors | 1998 |
[Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia; Lymphoma; Male; Myeloproliferative Disorders; Podophyllotoxin | 1986 |